Header Logo

Connection

SHUBHAM PANT to Cross-Over Studies

Back to Details
This is a "connection" page, showing publications SHUBHAM PANT has written about Cross-Over Studies.
SHUBHAM PANT
Connection Strength
0.032
Cross-Over Studies
  1. Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2016 Nov; 78(5):921-927.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.